NEULASTA (PEGFILGRASTIM) — FDA Approval BLA125031 (AMGEN)
NEULASTA (PEGFILGRASTIM) — FDA Approval BLA125031 (AMGEN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NEULASTA; Active ingredients: PEGFILGRASTIM; Application number: BLA125031.
| Brand name | NEULASTA |
|---|---|
| Active ingredients | PEGFILGRASTIM |
| Application number | BLA125031 |
| Sponsor | AMGEN |
| Dosage form | SYRINGE |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20020131 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →